A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.
Epistemonikos ID: 1329c9c7e4b3ec566c1b77c828d29aa3994ccab5
First added on: May 21, 2024